Mohammad Hirmand
- Pulmonary and Respiratory Medicine top 0.2%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Cancer Research top 1%
- Oncology top 2%
- Molecular Biology top 10%
- Co-authors
- Howard I. ScherKarim FizaziJohann S. de BonoMary‐Ellen TaplinCora N. SternbergLynn SeelyFred SaadKurt Miller
- Topics
- Prostate Cancer Treatment and Research (33 papers)Radiopharmaceutical Chemistry and Applications (21 papers)Cancer Treatment and Pharmacology (11 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Mohammad Hirmand
38 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Pulmonary and Respiratory Medicine 4.6k
- Radiology, Nuclear Medicine and Imaging 1.6k
- Cancer Research 1.6k
- Oncology 1.3k
- Molecular Biology 1.2k
Countries citing papers authored by Mohammad Hirmand
This map shows the geographic impact of Mohammad Hirmand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Hirmand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Hirmand more than expected).
Fields of papers citing papers by Mohammad Hirmand
This network shows the impact of papers produced by Mohammad Hirmand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Hirmand. The network helps show where Mohammad Hirmand may publish in the future.
Co-authorship network of co-authors of Mohammad Hirmand
This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Hirmand. A scholar is included among the top collaborators of Mohammad Hirmand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Hirmand. Mohammad Hirmand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 9 | |
| 3 | 80 | |
| 4 | 3 | |
| 5 | 31 | |
| 6 | 40 | |
| 7 | 34 | |
| 8 | 8 | |
| 9 | 71 | |
| 10 | 28 | |
| 11 | 151 | |
| 12 | 101 | |
| 13 | 10 | |
| 14 | 40 | |
| 15 | Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapybreakdown → | 3326 |
| 16 | 26 | |
| 17 | 96 | |
| 18 | Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 studybreakdown → | 809 |
| 19 | 6 | |
| 20 | 1 |
About Mohammad Hirmand
Mohammad Hirmand is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 38 papers that have together received 5.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (33 papers), Radiopharmaceutical Chemistry and Applications (21 papers) and Cancer Treatment and Pharmacology (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.6k citations), Cancer Research (1.6k citations) and Radiology, Nuclear Medicine and Imaging (1.6k citations). Mohammad Hirmand has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Howard I. Scher, Karim Fizazi, Johann S. de Bono, Mary‐Ellen Taplin, Cora N. Sternberg, Lynn Seely, Fred Saad, Kurt Miller, Ronald de Wit and Andrew J. Armstrong. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.